Literature DB >> 10524692

Objective and subjective sleep disturbances in patients with systemic lupus erythematosus.

M Valencia-Flores1, M Resendiz, V A Castaño, V Santiago, R M Campos, S Sandino, X Valencia, J Alcocer, G G Ramos, D L Bliwise.   

Abstract

OBJECTIVE: To assess objective and subjective evidence of sleep disorders in patients with systemic lupus erythematosus (SLE) and to examine correlations between parameters of lupus activity, depression, and sleep disturbances.
METHODS: Fourteen SLE patients and 11 normal control subjects of similar age underwent all-night polysomnography on 3 consecutive nights. The patients and controls were also evaluated for daytime sleepiness by the Multiple Sleep Latency Test and completed a sleep disorders questionnaire and the Beck Depression Inventory.
RESULTS: The polysomnographic data showed that sleep in SLE patients was characterized by respiratory and movement disorders. These intrinsic primary sleep disorders are related to the symptom of restless, poor sleep at night. Lupus patients were more sleepy during the day, and their sleepiness was related to sleep fragmentation, with more arousals and stage transitions than the control group. Disease activity was associated with decreases in sleep efficiency and delta sleep and with increases in sleep fragmentation. Depression was not correlated with the activity of the disease.
CONCLUSION: There is an enhanced presence of sleep disorders in patients with SLE. The most frequent primary sleep disorders are respiratory and movement disorders.

Entities:  

Mesh:

Year:  1999        PMID: 10524692     DOI: 10.1002/1529-0131(199910)42:10<2189::AID-ANR21>3.0.CO;2-V

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

1.  Fatigue in systemic lupus erythematosus.

Authors:  Grace E Ahn; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2012-04-01

2.  Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation.

Authors:  Jami A Kinnucan; David T Rubin; Tauseef Ali
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

3.  Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data.

Authors:  Nicholas T Vozoris; Richard S Leung
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

4.  Predictors of poor sleep quality in patients with systemic lupus erythematosus.

Authors:  M Inoue; K Shiozawa; R Yoshihara; T Yamane; Y Shima; T Hirano; K Makimoto
Journal:  Clin Rheumatol       Date:  2017-01-30       Impact factor: 2.980

5.  Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis.

Authors:  Domenico Paolo Emanuele Margiotta; Alice Laudisio; Luca Navarini; Fabio Basta; Carmen Mazzuca; Silvia Angeletti; Massimo Ciccozzi; Raffaele Antonelli Incalzi; Antonella Afeltra
Journal:  Clin Rheumatol       Date:  2019-01-28       Impact factor: 2.980

6.  Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study.

Authors:  M Haupt; S Millen; M Jänner; D Falagan; R Fischer-Betz; M Schneider
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

7.  Increased disease activity is associated with altered sleep architecture in an experimental model of systemic lupus erythematosus.

Authors:  Beatriz Duarte Palma; Sergio Tufik
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

8.  Self-reported sleep in systemic lupus erythematosus.

Authors:  Kenneth Mark Greenwood; Leah Lederman; Helen Dawn Lindner
Journal:  Clin Rheumatol       Date:  2008-04-12       Impact factor: 2.980

Review 9.  Living with systemic lupus erythematosus in the developing world.

Authors:  A Phuti; M Schneider; M Tikly; B Hodkinson
Journal:  Rheumatol Int       Date:  2018-03-26       Impact factor: 2.631

10.  Objective measures of disordered sleep in fibromyalgia.

Authors:  Ronald D Chervin; Mihaela Teodorescu; Ramesh Kushwaha; Andrea M Deline; Christine B Brucksch; Christine Ribbens-Grimm; Deborah L Ruzicka; Phyllis K Stein; Daniel J Clauw; Leslie J Crofford
Journal:  J Rheumatol       Date:  2009-08-14       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.